Ambrosia Biosciences Inc., a drug-discovery company launched last year, has added Jason Haddock, a former executive with ArcherDX Inc. and Array BioPharma Inc., to its board of directors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback